BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14748730)

  • 1. Circulating levels of the chemokines JE and KC in female C3H apolipoprotein-E-deficient and C57BL apolipoprotein-E-deficient mice as potential markers of atherosclerosis development.
    Parkin SL; Pritchett JP; Grimsditch DC; Bruckdorfer KR; Sahota PK; Lloyd A; Overend P; Benson GM
    Biochem Soc Trans; 2004 Feb; 32(Pt 1):128-30. PubMed ID: 14748730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3H apoE(-/-) mice have less atherosclerosis than C57BL apoE(-/-) mice despite having a more atherogenic serum lipid profile.
    Grimsditch DC; Penfold S; Latcham J; Vidgeon-Hart M; Groot PH; Benson GM
    Atherosclerosis; 2000 Aug; 151(2):389-97. PubMed ID: 10924715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic backgrounds but not sizes of atherosclerotic lesions determine medial destruction in the aortic root of apolipoprotein E-deficient mice.
    Shi W; Brown MD; Wang X; Wong J; Kallmes DF; Matsumoto AH; Helm GA; Drake TA; Lusis AJ
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1901-6. PubMed ID: 12920047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal relationships between circulating levels of CC and CXC chemokines and developing atherosclerosis in apolipoprotein E*3 Leiden mice.
    Murphy N; Bruckdorfer KR; Grimsditch DC; Overend P; Vidgeon-Hart M; Groot PH; Benson GM; Graham A
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1615-20. PubMed ID: 12842836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherosclerosis in C3H/HeJ mice reconstituted with apolipoprotein E-null bone marrow.
    Shi W; Wang X; Tangchitpiyanond K; Wong J; Shi Y; Lusis AJ
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):650-5. PubMed ID: 11950705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neointimal formation in two apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility.
    Shi W; Pei H; Fischer JJ; James JC; Angle JF; Matsumoto AH; Helm GA; Sarembock IJ
    J Lipid Res; 2004 Nov; 45(11):2008-14. PubMed ID: 15314103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice.
    Lee TS; Shiao MS; Pan CC; Chau LY
    Circulation; 1999 Mar; 99(9):1222-9. PubMed ID: 10069791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low circulating insulin-like growth factor I increases atherosclerosis in ApoE-deficient mice.
    Shai SY; Sukhanov S; Higashi Y; Vaughn C; Rosen CJ; Delafontaine P
    Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1898-906. PubMed ID: 21335474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Zhang W; Yancey PG; Su YR; Babaev VR; Zhang Y; Fazio S; Linton MF
    Circulation; 2003 Nov; 108(18):2258-63. PubMed ID: 14581413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative trait locus analysis of carotid atherosclerosis in an intercross between C57BL/6 and C3H apolipoprotein E-deficient mice.
    Li Q; Li Y; Zhang Z; Gilbert TR; Matsumoto AH; Dobrin SE; Shi W
    Stroke; 2008 Jan; 39(1):166-73. PubMed ID: 18048852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic background determines the extent of atherosclerosis in ApoE-deficient mice.
    Dansky HM; Charlton SA; Sikes JL; Heath SC; Simantov R; Levin LF; Shu P; Moore KJ; Breslow JL; Smith JD
    Arterioscler Thromb Vasc Biol; 1999 Aug; 19(8):1960-8. PubMed ID: 10446078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice.
    Desai A; Zhao Y; Warren JS
    Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice.
    Detmers PA; Hernandez M; Mudgett J; Hassing H; Burton C; Mundt S; Chun S; Fletcher D; Card DJ; Lisnock J; Weikel R; Bergstrom JD; Shevell DE; Hermanowski-Vosatka A; Sparrow CP; Chao YS; Rader DJ; Wright SD; Puré E
    J Immunol; 2000 Sep; 165(6):3430-5. PubMed ID: 10975863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin Attenuates Progression of Atherosclerosis and Reduces Serum IL6 and CCL2 Levels in Apolipoprotein-E-deficient Mice.
    Tsilimigras DI; Thanopoulou K; Salagianni M; Siasos G; Oikonomou E; Perrea DD; Nirakis N; Filis K; Tsioufis K; Tousoulis D; Sigala F
    In Vivo; 2023; 37(3):994-1002. PubMed ID: 37103114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice.
    Wassmann S; Czech T; van Eickels M; Fleming I; Böhm M; Nickenig G
    Circulation; 2004 Nov; 110(19):3062-7. PubMed ID: 15277329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary antioxidants decrease serum soluble adhesion molecule (sVCAM-1, sICAM-1) but not chemokine (JE/MCP-1, KC) concentrations, and reduce atherosclerosis in C57BL but not apoE*3 Leiden mice fed an atherogenic diet.
    Murphy N; Grimsditch DC; Vidgeon-Hart M; Groot PH; Overend P; Benson GM; Graham A
    Dis Markers; 2005; 21(4):181-90. PubMed ID: 16403953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping, genetic isolation, and characterization of genetic loci that determine resistance to atherosclerosis in C3H mice.
    Wang SS; Shi W; Wang X; Velky L; Greenlee S; Wang MT; Drake TA; Lusis AJ
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2671-6. PubMed ID: 17916774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice.
    Aalto-Setälä K; Laitinen K; Erkkilä L; Leinonen M; Jauhiainen M; Ehnholm C; Tamminen M; Puolakkainen M; Penttilä I; Saikku P
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):578-84. PubMed ID: 11304476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage cholesterol metabolism, apolipoprotein E, and scavenger receptor AI/II mRNA in atherosclerosis-susceptible and -resistant mice.
    Friedman G; Ben-Yehuda A; Dabach Y; Hollander G; Babaey S; Ben-Naim M; Stein O; Stein Y
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2459-64. PubMed ID: 11073853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taurine inhibits development of atherosclerotic lesions in apolipoprotein E-deficient mice.
    Kondo Y; Toda Y; Kitajima H; Oda H; Nagate T; Kameo K; Murakami S
    Clin Exp Pharmacol Physiol; 2001 Oct; 28(10):809-15. PubMed ID: 11553020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.